drugset / Trial / NCT00143442

Study of [S,S]-Reboxetine in Patients With Postherpetic Neuralgia, Who Are Gabapentin Treatment Failures

NCT00143442

Phase 2 Completed 184 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the effectiveness of \[S,S\]-Reboxetine in the treatment of chronic pain following a shingles infection in patients who are Gabapentin treatment failures.

Timeline

Start
2003-12
Primary completion
Completion
2004-10

Drugs

EvaluationDrugModalityDoseRoute
Subject [S,S]-Reboxetine Unknown

Indications

No indication recorded.